Dr. Glenn Gormley is the senior executive officer and global head of R&D for Daiichi Sankyo Co., Ltd., and the execu-tive chairman and president of Daiichi Sankyo, Inc. A leading pharmaceutical company in Japan, Daiichi Sankyo has developed a diverse portfolio of medicines and is committed to the development of new and innovative treatments for cancer patients.
Glenn was born in Philadelphia and educated at UCLA, New York University, and the University of Chicago where he earned his M.D. and Ph.D. He is board certified in pediatrics and pediatric endo-crinology, and holds an array of awards and acknowledgements for his services to healthcare, such as the MacArthur Foundation Research Award and the Pfizer Fellowship Award. He began his career at Merck, where he first learned how to develop new medications for those in need.
A second-generation Irishman, Glenn has traced his paternal roots to just outside of Belfast. “My Irish family passed on to me a strong work ethic and the belief that I could accomplish anything I set my mind to and be who I wanted to be, without compromise,” he says. Glenn and his wife Anne live in New Jersey and have three children, Adam, Julia, and Ellen.